BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 24615771)

  • 1. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
    Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
    Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Facciorusso A; Del Prete V; Antonino M; Crucinio N; Neve V; Di Leo A; Carr BI; Barone M
    Dig Liver Dis; 2014 Nov; 46(11):1014-9. PubMed ID: 25085684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.
    Minami Y; Chung H; Kudo M; Kitai S; Takahashi S; Inoue T; Ueshima K; Shiozaki H
    AJR Am J Roentgenol; 2008 Jun; 190(6):W335-41. PubMed ID: 18492875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound.
    Song KD; Lee MW; Rhim H; Cha DI; Chong Y; Lim HK
    AJR Am J Roentgenol; 2013 Nov; 201(5):1141-7. PubMed ID: 24147489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography.
    Nakai M; Sato M; Sahara S; Takasaka I; Kawai N; Minamiguchi H; Tanihata H; Kimura M; Takeuchi N
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):62-9. PubMed ID: 18987911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
    Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound fusion imaging of hepatocellular carcinoma: a review of current evidence.
    Minami Y; Kudo M
    Dig Dis; 2014; 32(6):690-5. PubMed ID: 25376285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.